Multiple Sclerosis Discovery Forum

Inspiring Connections

Most Viewed

The low EOMES/TBX21 molecular phenotype in multiple sclerosis reflects CD56+ cell dysregulation and is affected by immunomodulatory therapies.
Ampyra (Fampyra)
The 10th European Congress of Neuropathology
Fumarate treatment in progressive forms of multiple sclerosis: first results of a single-center observational study.
Neuroinflammation increases GABAergic tone and impairs cognitive and motor function in hyperammonemia by increasing GAT-3 membrane expression. Reversal by sulforaphane by promoting M2 polarization of microglia.
Geography in multiple sclerosis.
Glatiramer acetate inhibits degradation of collagen II by suppressing the activity of interferon regulatory factor-1.
Antagonism of histamine H4 receptor exacerbates clinical and pathological signs of experimental autoimmune encephalomyelitis.
CNS vasculitis in a patient with MS on daclizumab monotherapy.
Use of rituximab in multiple sclerosis: current progress and future perspectives.
Intramuscular interferon beta-1a therapy initiated during a first demyelinating event in multiple sclerosis. CHAMPS Study Group.
FDA product review for daclizumab
Myeloid cell transmigration across the CNS vasculature triggers IL-1β-driven neuroinflammation during autoimmune encephalomyelitis in mice.
Pattern of remyelination in the CNS.
'Clinically definite benign multiple sclerosis', an unwarranted conceptual hodgepodge: evidence from a 30-year observational study.
Inhibition of dihydroorotate dehydrogenase by the immunosuppressive agent leflunomide.
Synergistic Effects of Reserve and Adaptive Personality in Multiple Sclerosis.
Biomarkers of disease activity in multiple sclerosis.
Quality of life outcomes with BG-12 (dimethyl fumarate) in patients with relapsing-remitting multiple sclerosis: The DEFINE study.
Treatment with retinoid X receptor agonist IRX4204 ameliorates experimental autoimmune encephalomyelitis.
Effects of fumaric acid esters on blood-brain barrier tight junction proteins.
Parainfectious longitudinally extensive transverse myelitis associated with varicella-zoster virus.
Flupirtine as Oral Treatment in Multiple Sclerosis (FLORIMS)
Daclizumab in multiple sclerosis: a high-yield extension study.
UCSF Seminar: "How do we get a myelinated brain? A new model for distribution of oligodendrocytes throughout the developing CNS"

Pages